In the Deloitte Sweden Technology Fast 50, C-RAD placed third in the ranks of fastest-growing companies. The ranking considers revenue growth over the last five years.
The ranking includes technology companies in a number of sectors. In the overall ranking C‑RAD is the 19th fastest-growing company. C-RAD successfully made the ranks in 2013 as well.
Deloitte Sweden Technology Fast 50 is the only cross-industry ranking of technology companies in Sweden, and is now in its eleventh year. The ranking includes public and private companies, large and small, in every technology sector, from Internet specialists to life sciences and green tech, and from computers, semiconductors and software to telecommunications. Growth is measured as revenue growth over the last five years according to annual reports filed 2009-2013 with the Swedish Companies Registration Office per July 31, 2014.
“This is a fantastic result,” says Tim Thurn, CEO of C-RAD. “Our excellent team is the whole reason for this success. In the past few years we have focused on expanding our international sales organization in key markets as well as on optimizing our technology to serve the clinical needs of customers. There is still high growth potential in the current product portfolio.”
About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. , all of which are located in Uppsala, Sweden. Numbers of employees are currently 27 people. C-RAD’s business originates from research and development at Karolinska Institutet in Solna, Sweden. Sales of the company’s first product, the C-RAD SentinelTM, started in 2007. Cooperation agreements have been signed with Elekta (Sweden), Varian (USA) and IBA (Belgium). C-RAD is represented by distributors specialized in radiation therapy on major markets. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. C-RAD holds 29% of the laser company Cyrpa with an option to acquire the remaining 71%. C-RAD AB is listed since March 2010 on NASDAQ OMX First North Premier. Erik Penser Bankaktiebolag is appointed as C‑RAD’s Certified Adviser.
For more information on C-RAD, please visit www.c-rad.com.
For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666947, E-mail investors@c-rad.com
The above information is price-sensitive and must therefore be disclosed under the Securities Market Act (2077:528).
